Fertility Drug Market Trends, Size, Forecast - 2018-2023

Infertility is one of the major issue now a day due to change in life style & cultural shift. There are various fertility drugs available in market for infertility related problems. Fertility drugs enhance the reproductive ability by improving quality of egg or sperms by increasing the levels of certain hormones in human body. The major factors that are responsible for the growth of fertility drug market are Change in lifestyle and Cultural shift, increasing prevalence of obesity, increasing infertility rate in adults, rising average age of conceiving in woman and Rise in sexually transmitted diseases among men and women. However, high cost of fertility drugs & risk associated with the use of fertility drugs such as Ovarian Hyperstimulation Syndrome (OHS) are the major constraints to the market. Whereas increasing awareness about the fertility drugs among the people is creating immense opportunities for future.

Request a free sample of our report on Fertility Drug Market: https://www.omrglobal.com/request-sample/fertility-drug-market

On the basis of geography, the market has been divided into North America, Europe, Asia Pacific and Rest of the World. Europe is expected to dominate in the global fertility drug market owing to high prevalence of infertility in the UK, France, Germany and other European countries. Large customer base, high consumption of Tabaco & smoking, continuous increment in economy and healthcare facility are the major factor for the growth of the market in the APAC region.
Large number of pharmaceutical companies are active in fertility drug market. The major companies active in the market are Berlex Laboratories, Inc., Baxter Healthcare Corp., Ferring Pharmaceutical Inc., Janssen Pharmaceutical Inc., Pfizer, Takeda Pharmaceutical co. ltd., Procter & Gamble Pharmaceutical and so on. The companies are focusing on product innovations, expansions, M&A, finding new market or innovate in their core competency in order to expand individual market share.

A full report of Fertility Drug Market is available at: https://www.omrglobal.com/industry-reports/fertility-drug-market

Global Fertility Drugs Market Segmentation

By gender type
• female fertility treatment
• male fertility treatment

By treatment type
• hormonal
• in vitro fertilization(ivf)
• intra cytoplasmic sperm injection(icsi)
• intrauterine insemination(iui)
• alternative & complementary treatment

By infertility type
• problem with ovulating
• unexplained infertility
• blocked or damaged tubes
• endometriosis
• polycystic ovarian syndrome

Competitive landscape
• key strategies
• key company analysis

Regional Analysis

• north american
o united states
o Canada

• europe
o uk
o germany
o spain
o france
o italy
o rest of europe

• apac
o india
o china
o japan
o rest of apac
• rest of the world

Company Profile
• Berlex laboratories, inc.
• Eli lilly
• Baxter healthcare corporation
• Ferring pharmaceuticals, inc.
• Merck & co. Pharmaceutical company
• Noven pharmaceuticalorganon, inc.
• Janssen pharmaceuticals inc.
• Personal products company
• Pfizer, inc.
• Procter & gamble pharmaceuticals

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/fertility-drug-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.